This year marks the 40th anniversary of the cardiothoracic surgery organization, and it has a big celebration planned.
From PAD to pulmonary embolism and stroke, the meeting promises to be packed with cutting-edge vascular therapy news.
Two new observational studies add to the growing evidence base on cardiovascular risks associated with hormone replacement ...
ESC 2026 captured the biggest share of our top slots, but readers were most keen to learn about the first FDA approval of ...
Identifying regions with expertise can improve how patients access those best at managing the disease, Richard Soucier says.
A retrospective analysis shows that when CMR and FDG PET/CT findings are concordant, patients are more vulnerable to events.
A key message is that clinicians need to include nutrition discussions as part of routine care, Frank Hu says.
The Autus surgically implanted device, made by Edwards Lifesciences, is also novel for its leaflets consisting of ePTFE.
Experts urge clinicians to focus on stroke prevention benefits when counseling patients about carotid revascularization.
Mavacamten (Camzyos) is now approved by the US Food and Drug Administration for use not only in adults, but also in pediatric patients with obstructive hypertrophic cardiomyopathy (HCM) who weigh at ...
Virtual reality calms claustrophobia, tweaking trial recruitment, multidisciplinary TAVI recovery efforts, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results